What Is The Predicted Revenue Outlook For The Global Opioid-Induced Constipation Treatment Market To Surpass $2.42 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The Opioid-Induced Constipation Treatment Market?
There has been substantial growth in the market size of opioid-induced constipation treatment in the past few years. The market is projected to expand from $1.78 billion in 2024 to $1.9 billion in 2025, registering a compound annual growth rate (CAGR) of 6.7%. The considerable growth during the previous years can be linked to the growing elderly population, customized OIC treatments, access to effective OIC medication, an escalating trend of opioid usage, and an increasing occurrence of gastrointestinal ailments.
The market surrounding treatments for opioid-induced constipation is anticipated to witness robust expansion in the coming years, potentially reaching a value of $2.42 billion in 2029 with a compound annual growth rate (CAGR) of 6.3%. This forecasted growth could be driven by factors such as rapid approval processes for drugs, a rise in opioid analgesic prescriptions, enhanced regulations in Research and Development of new treatments, and the growth in biologics development. Key trends expected throughout the forecast duration include heightened patient knowledge and awareness, the development of targeted therapies, non-pharmacological treatment approaches, advancements in biotechnology, and increased financial investment in the sector.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15881&type=smp
Which Industry Forces Are Driving The Opioid-Induced Constipation Treatment Market Forward?
The growth of the opioid-induced constipation treatment market is predicted to be fueled by the increasing use of opioids for managing both cancer-related and non-cancer-related pain. Cancer pain is associated with the disease itself and its related treatments while non-cancer pain represents pain arising from conditions not related to cancer. The increase in opioid administration for these types of pain is attributed to the necessity to effectively control moderate to severe pain, taking into account variables such as the intensity and duration of the pain, patient’s reaction to alternative treatments and the ultimate aim of enhancing the quality of life while minimizing the possible risks of addiction and side effects. The treatment of opioid-induced constipation (OIC) helps both cancer and non-cancer pain patients by easing constipation brought on by opioid usage, improving overall comfort, compliance to pain management plans and quality of life without hindering pain relief. For instance, the Government of Canada reported in May 2021 that up to 8.3 million Canadians could suffer from chronic pain by 2025, which is projected to rise to about 9.0 million by 2030. Consequently, this increase in the administration of opioids for both cancer and non-cancer pain is triggering the expansion of the opioid-induced constipation treatment market.
How Is The Opioid-Induced Constipation Treatment Market Organized By Different Segments?
The opioid-induced constipation treatmentmarket covered in this report is segmented –
1) By Drug Class: Laxatives; Peripherally Acting μ-opioid Receptor Antagonists; Serotonin Receptor Agonists; Prostaglandin
2) By Type: Oral; Parenteral
3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
Subsegments:
1) By Laxatives: Osmotic Laxatives; Stimulant Laxatives; Bulk-Forming Laxatives
2) By Peripherally Acting μ-Opioid Receptor Antagonists: Naloxegol; Methylnaltrexone; Alvimopan
3) By Serotonin Receptor Agonists: Prucalopride; Tegaserod
4) By Prostaglandin: Lubiprostone
What Current And Upcoming Trends Are Shaping The Opioid-Induced Constipation Treatment Market?
In an attempt to develop innovative medicines, leading enterprises in the opioid-induced constipation treatment market are embracing the approach of strategic collaborations. This not only allows these companies to pool their resources and expertise, but also strengthens their research and development prowess, widens their market footprint, and speeds up commercialization, thereby fostering innovation and growth within this industry. For example, in November 2022, Kyowa Kirin Co. Ltd, a biotechnology firm from Japan, collaborated with Grünenthal GmbH, a German pharmaceutical organization, aiming to amalgamate their patient solutions. Through this collaboration, they aim to boost the growth and worldwide accessibility of a range of transformational pain management medicines, which include treatments for opioid-induced constipation, unprecedented cancer-related pain, and osteoporosis.
Who Are The Primary Market Leaders In The Opioid-Induced Constipation Treatment Market?
Major companies operating in the opioid-induced constipation treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Chemical Pharma Co. Ltd., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH., Shionogi & Co. Ltd., Ono Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Mundipharma International Limited, Lantheus Holdings Inc., Indivior plc, Mallinckrodt Pharmaceuticals, Collegium Pharmaceutical Inc., Ironwood Pharmaceuticals Inc., Cosmo Pharmaceuticals SA, Nektar Therapeutics, RedHill Biopharma Ltd., Theravance Biopharma Inc., Cumberland Pharmaceuticals Inc., Valinor Pharma LLC
Access The Complete Report Here:
How Do Regional Dynamics Influence The Opioid-Induced Constipation Treatment Market Performance?
North America was the largest region in the opioid-induced constipation treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioid-induced constipation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15881&type=smp
Browse Through More Reports Similar to the Global Opioid-Induced Constipation Treatment Market 2025, By The Business Research Company
Merkel Cell Carcinoma Treatment Global Market Report 2025
Basal Cell Carcinoma Treatment Global Market Report 2025
Crohns Disease Cd Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
